About Lancaster Laboratories
Lancaster Laboratories is a company based in Lancaster (United States) founded in 1961 by Earl H Hess was acquired by Eurofins Scientific in February 2011. Lancaster Laboratories operates in a competitive market with competitors including Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.
- Headquarter Lancaster, United States
- Founders Earl H Hess
- SectorsHealthcare
- Website lancasterlabs.com
- Social LinkedIn
- Acquired by Eurofins Scientific (Feb 2011)
- InvestorsEurofins Scientific
& 1 more
- Acquired by
Investors in Lancaster Laboratories
Lancaster Laboratories has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eurofins Scientific and Goldner Hawn.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Goldner Hawn is engaged in private equity investments. | 1989 | goldnerhawn.com | Minneapolis, United States | |
Laboratory testing and contract research services are provided globally. | 1987 | eurofins.com | Luxembourg, Luxembourg |
Investor details for Lancaster Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lancaster Laboratories
1 people are tracked at Lancaster Laboratories (1 in leadership).
| Name | Role | Group |
|---|---|---|
Earl H Hess | Founder | Leadership |
Complete people profiles for Lancaster Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lancaster Laboratories
3 dated milestones of Lancaster Laboratories across 50 years, from founding to its latest funding, stage changes and deals.
- Founded Lancaster Laboratories is founded.
- Exit Acquired by Goldner Hawn.
- Exit Acquired by Eurofins Scientific.
Competitors of Lancaster Laboratories
Lancaster Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $255.15M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| clinigengroup.com | 2010 | Burton-on-trent, United Kingdom | – | – | Specialty medicines are supplied via clinical trials and access programs. | |
| zuelligpharma.com | 1992 | Singapore | – | – | Healthcare access in Asia is enhanced by Zuellig Pharma. | |
| fishawack.com | 2001 | Brighton, United Kingdom | $23.59M | 45 | Fully integrated cross-border services are delivered to global pharmaceutical organizations. | |
| diaceutics.com | 2005 | Belfast, United Kingdom | – | 133 | Precision medicine integration is facilitated through analytics and services. | |
| sciencegroup.com | 1995 | Cambridge, United Kingdom | – | 431 | Technology-based consultancy and product development services are provided. | |
| clearviewhcp.com | 2008 | Newton, United States | – | 381 | Strategic consulting services are provided to life sciences companies. |
Detailed competitors of Lancaster Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lancaster Laboratories
Websites that share an audience with Lancaster Laboratories (lancasterlabs.com).
Websites whose visitors overlap most with Lancaster Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pacelabs.com | 100% | 47K | #479,636 | View details | |
palnwa.com | palnwa.com | 92% | – | – | – |
qclaboratories.com | qclaboratories.com | 82% | – | – | – |
analytical-lab.com | analytical-lab.com | 82% | – | – | – |
anamol.com | anamol.com | 82% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for Lancaster Laboratories
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Lancaster Laboratories
10 companies that operate in the same segment as Lancaster Laboratories (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lancaster Laboratories
Lancaster Laboratories was founded in 1961.
Lancaster Laboratories is headquartered in Lancaster, United States. It is registered at Lancaster, Pennsylvania, United States.
Lancaster Laboratories was established in 1961 in Lancaster, United States. Services encompassing regulatory compliance, marketing support, and consulting are delivered to the biopharma sector. Operations center on assisting biotechnology and pharmaceutical companies with development processes, market entry strategies, and advisory needs. The firm maintains its primary location in the United States, focusing on factual support for industry stakeholders without broader international expansion noted.
Lancaster Laboratories's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Lancaster Laboratories has 2 investors. Key investors include Eurofins Scientific, and Goldner Hawn.
Yes. Lancaster Laboratories was acquired by Eurofins Scientific in February 2011.